These reports outline the MHRA’s Corporate and Business Plans, detailing the agency’s strategic direction over the next three years.
Focusing on keeping patients safe and enabling access to high quality, safe and effective medical products. Contents include the priority actions and activities which the agency will take forward to ensure delivery of the statutory role and functions of the agency.
Following an extensive process of internal and external engagement, our ambitions have been prioritised and are focused on the following four strategic priorities over the next three years:
To continue reading this article please go to GOV.UK .